We are a not-for-profit organization of pharmaceutical and biotechnology companies with the mission of advancing science and technology to augment the capability of member companies to develop transformational solutions that benefit patients, regulators and the broader R&D community.
September 2020
IQ BioCMC LG Subvisible Particles Working Group Case Study presents a Multi-company Assessment of Submicron Particle Levels in Biotechnology-derived Protein Products
August 2020
Open Public Call: IQ DILI Causality Assessment Working Group issues call for technical/scientific experts in hepatology with knowledge and experience in DILI and in drug development.
